WEDNESDAY, Nov. 12, 2024 (HealthDay News) -- Overtreatment of prostate cancer is increasing in the United States among men ...

On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

He further noted that active surveillance is generally recommended for patients diagnosed with early-stage, low-grade ...

Prostate cancer occurs when abnormal cells grow and multiply in the prostate gland This condition can have a significant ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Prostate cancer can be classified as the second most common and lethal cancer among men on the planet after skin cancer.

The completion of enrollment of the SOLAR-RECUR trial is yet another significant milestone for Curium. Cu 64 PSMA I&T represents an important pillar in the development of our theranostic program for ...

Overscreening and overtreatment of men with prostate cancer and limited life expectancy continue to be an ongoing issue in the era of active surveillance.

Discover a recent study that revealed that patients treated for prostate cancer, particularly with radiotherapy, have an ...